SYRE Stock Price & Quote | Spyre Therapeutics, Inc. Common Stock | FurlPay
Spyre Therapeutics, Inc. Common Stock (SYRE) Stock Price
Spyre Therapeutics, Inc. Common Stock (NASDAQ: SYRE) last traded at $106.49, down 1.21% on the session. The quote above updates while this page is open; the figures below are drawn from Spyre Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Spyre Therapeutics, Inc. Common Stock (SYRE) company overview
Spyre Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker SYRE. Its market capitalisation is $9.39 billion.
SYRE valuation
Valuation measures for Spyre Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
Market cap
$9.39B
Enterprise value
$9.30B
Price / book
8.53
Beta
1.86
SYRE financials
Trailing-twelve-month figures tagged in Spyre Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
Revenue (TTM)
$0.00
Net income (TTM)
-$178.92M
Return on equity
-16.25%
Cash
$162.01M
SYRE trading statistics
Range and volume for SYRE over the past 52 weeks.
52-week high
$110.18
52-week low
$14.51
Volume
909.3K
Average volume
1.24M
Previous close
$107.79
Spyre Therapeutics, Inc. Common Stock (SYRE) FAQs
What is the SYRE stock price today?
Spyre Therapeutics, Inc. Common Stock (SYRE) last traded at $106.49, down 1.21% on the session. FurlPay quotes SYRE from Yahoo Finance and stamps each figure with the exchange time it printed.
What exchange is SYRE listed on?
Spyre Therapeutics, Inc. Common Stock is listed on NASDAQ under the ticker symbol SYRE.
What is Spyre Therapeutics, Inc. Common Stock's market cap?
Spyre Therapeutics, Inc. Common Stock has a market capitalisation of $9.39 billion, derived from its shares outstanding as reported in its SEC filings and the latest quoted price.
What is SYRE's 52-week range?
Over the past 52 weeks SYRE has traded between $14.51 and $110.17.
Data sources
Price, range and volume — Yahoo Finance. Quotes may be delayed; each carries the exchange timestamp it printed with.
Financials and valuation — the company’s own XBRL filings with the U.S. Securities and Exchange Commission (CIK 0001636282), period ending 2025-12-31.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.